...
首页> 外文期刊>Journal of Radiation Research: Official Organ of the Japan Radiation Research Society >Linac-based stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannomas: comparative observations of 139 patients treated at a single institution
【24h】

Linac-based stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannomas: comparative observations of 139 patients treated at a single institution

机译:基于直线加速器的立体定向放射外科手术和分段立体定向放射治疗前庭神经鞘瘤:单机构接受治疗的139例患者的比较观察

获取原文
获取原文并翻译 | 示例
           

摘要

Stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (SRT) have been recognized as an alternative to surgery for small to medium sized vestibular schwannoma (VS). This study analysed and compared the outcomes of VS treated with the first Thailand installation of a dedicated Linac-based stereotactic radiation machine using single-fraction radiosurgery (SRS), hypofraction stereotactic radiotherapy (HSRT) and conventional fraction stereotactic radiotherapy (CSRT). From 1997 to 2010, a total of 139 consecutive patients with 146 lesions of VS were treated with X-Knife at Ramathibodi hospital, Bangkok, Thailand. SRS was selected for 39 lesions (in patients with small tumors ≤3 cm and non-serviceable hearing function), whereas HSRT (79 lesions) and CSRT (28 lesions) were given for the remaining lesions that were not suitable for SRS. With a median follow-up time of 61 months (range, 12-143), the 5-year local control rate was 95, 100 and 95% in the SRS, HSRT and CSRT groups, respectively. Hearing preservation was observed after SRS in 75%, after HSRT in 87% and after CSRT in 63% of the patients. Cranial nerve complications were low in all groups. There were no statistically significant differences in local control, hearing preservation or complication between the treatment schedules. In view of our results, it may be preferable to use HSRT over CSRT for patients with serviceable hearing because of the shorter duration of treatment.
机译:立体定向放射外科手术(SRS)和分段立体定向放射治疗(SRT)已被视为中小型前庭神经鞘瘤(VS)手术的替代方法。这项研究分析并比较了泰国在泰国的第一台基于Linac的专用立体定向放射仪的单头放射外科手术(SRS),低度立体定向放射疗法(HSRT)和常规立体定向放射疗法(CSRT)的治疗效果。从1997年到2010年,泰国曼谷Ramathibodi医院共用X刀治疗了139例VS病变的139例连续患者。 SRS被选择用于39个病变(对于≤3 cm的小肿瘤且听力功能无法正常使用的患者),而剩余的不适合SRS的病变则采用HSRT(79个病变)和CSRT(28个病变)。 SRS,HSRT和CSRT组的中位随访时间为61个月(范围12-143),其5年局部控制率分别为95%,100%和95%。 SRS后有75%,HSRT后有87%和CSRT后有63%的患者观察到听力得到了保留。所有组的颅神经并发症发生率均较低。治疗方案之间在局部控制,听力保护或并发症方面无统计学差异。鉴于我们的结果,对于听力可服务的患者,最好使用HSRT而不是CSRT,因为治疗时间较短。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号